Evidence for Reactivation of Human Herpesvirus 6 in Generalized Lymphadenopathy in a Patient with Drug-Induced Hypersensitivity Syndrome-Reference-Cited by-同舟云学术

Evidence for Reactivation of Human Herpesvirus 6 in Generalized Lymphadenopathy in a Patient with Drug-Induced Hypersensitivity Syndrome

Published:2013-06 Issue:6 Volume:51 Page:1979-1982
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Saraya Takeshi¹,Mikoshiba Michiaki²,Kamiyama Harumi³,Yoshizumi Masakazu⁴,Tsuchida Shigeru³,Tsukagoshi Hiroyuki⁴,Ishioka Taisei⁴,Terada Miho³,Tanabe Eiichi⁵,Tomioka Chizuko³,Ishii Haruyuki¹,Kimura Hirokazu⁶,Kozawa Kunihisa⁴,Shiohara Tetsuo⁷,Takizawa Hajime¹,Goto Hajime¹

Affiliation:

1. Department of Respiratory Medicine, Kyorin University School of Medicine, Tokyo, Japan

2. Department of Hematology and Oncology, Japan Red Cross Musashino Hospital, Tokyo, Japan

3. Department of Pathology, Gunma Prefectural Cancer Center, Gunma, Japan

4. Gunma Prefectural Institute of Public Health and Environmental Sciences, Gunma, Japan

5. Department of Psychiatry, Jiundo Naika Hospital, Tokyo, Japan

6. National Institute of Infectious Diseases, Tokyo, Japan

7. Department of Dermatology, Kyorin University School of Medicine, Tokyo, Japan

Abstract

ABSTRACT The present case provides direct evidence of human herpesvirus 6 reactivation in resected lymph node tissue in a patient with drug-induced hypersensitivity syndrome. This case clearly demonstrates that appropriate pathological evaluation of lymphadenopathy for drug-induced hypersensitivity syndrome, which mimics malignant lymphoma in clinical, radiological, and pathological findings, is required.

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.00097-13

Reference13 articles.

1. Real-Time PCR for Quantification of Human Herpesvirus 6 DNA from Lymph Nodes and Saliva

2. Human Herpesvirus 6 Reactivation in Drug-induced Hypersensitivity Syndrome and DRESS Validation Score

3. The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations;Shiohara T;Br. J. Dermatol,2007

4. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?;Kardaun SH;Br. J. Dermatol,2007

5. Lymphadenopathy induced by anticonvulsant drugs and mimicking clinically pathologically malignant lymphomas;Saltzstein SL;Cancer,1959

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunopathogenic Insights on Preferential Human Herpesvirus-6 Reactivation in Drug Rash With Eosinophilia and Systemic Symptoms: A Scoping Review;Journal of Cutaneous Medicine and Surgery;2023-05-25

2. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Focus on the Pathophysiological and Diagnostic Role of Viruses;Microorganisms;2023-01-30

3. Morphologic Spectrum of Lymphadenopathy in Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome;ARCH PATHOL LAB MED;2022

4. Morphologic Spectrum of Lymphadenopathy in Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome;Archives of Pathology & Laboratory Medicine;2021-12-13

5. Chemokines in Severe Cutaneous Adverse Reactions (SCARs);Biomolecules;2021-06-06